U.S. Pulls Vaccine Funding from Gavi: Global Health at Risk
- Admin
- Jun 27
- 3 min read

In a controversial and potentially devastating move, U.S. Health Secretary Robert F. Kennedy Jr. has announced that the United States will withdraw all funding from Gavi, the global vaccine alliance credited with immunizing over one billion children and saving an estimated 18 million lives since its inception. The announcement, delivered via a recorded message at Gavi’s donor meeting in Brussels, sent shockwaves through the global public health community.
The implications are profound: millions of children in low-income countries now face increased risk of deadly, preventable diseases such as measles, tetanus, and polio, as the alliance scrambles to fill the funding gap left by one of its largest donors.
Why the Withdrawal? Kennedy’s Vaccine Skepticism Takes Center Stage
Robert F. Kennedy Jr., a long-time vaccine skeptic, justified the decision by accusing Gavi of “ignoring the science,” losing public trust, and stifling dissent during the COVID-19 pandemic. He specifically targeted:
Gavi’s collaboration with the World Health Organization (WHO) during the pandemic, claiming it silenced "legitimate questions."
Routine vaccines like DTP (diphtheria, tetanus, pertussis), which he alleged have been linked to higher mortality in young girls — a claim that has been debunked by health experts and lacks causal evidence.
Funding transparency, calling for Gavi to account for the $8 billion U.S. contribution since 2001.
Kennedy’s stance, while aligning with fringe skepticism, marks a radical departure from decades of bipartisan U.S. support for global vaccination programs.
Gavi’s Lifesaving Legacy at Risk
Gavi is a cornerstone of international health equity, operating as a public-private partnership between WHO, UNICEF, the World Bank, and the Bill & Melinda Gates Foundation. Its mission: to ensure access to life-saving vaccines in the world’s poorest regions.
Prior to this announcement, the U.S. had pledged $1 billion through 2030. That pledge is now void.
Health professionals and international agencies fear catastrophic consequences:
Doctors Without Borders warned that “countless children will die” as a result of the defunding.
Dr. Paul Offit, director at the Children’s Hospital of Philadelphia, called the move “incredibly dangerous,” saying it will "reverse decades of progress against infectious diseases."
Gavi responded, reaffirming its evidence-based approach and dedication to child health, noting the DTP vaccine has halved childhood mortality globally.
The Real Cost: A Setback for Global Health Security
The withdrawal signals a broader ideological shift in U.S. health policy, from science-driven global cooperation to nationalist, anti-establishment rhetoric. It also raises immediate challenges:
Gavi’s $9 billion fundraising goal for the next five years is now under threat.
The world’s most vulnerable populations, already facing unstable health systems, could see sharp increases in outbreaks and preventable deaths.
Other donor nations may be forced to increase contributions or re-evaluate their participation in global health programs.
Moreover, the timing is critical. The world is still recovering from the COVID-19 pandemic, and disruptions to vaccination programs could result in surges of disease not seen in decades.
A New Direction for U.S. Health Agencies?
Kennedy’s remarks come amid a larger restructuring of vaccine oversight. Earlier this month, he disbanded the existing 17-member U.S. vaccine advisory panel, replacing it with a smaller, seven-member team composed of known vaccine skeptics. This new body is expected to reshape public health messaging and federal vaccination policy going forward.
Critics fear this could erode trust in domestic immunization programs, with ripple effects across schools, hospitals, and community clinics in the U.S.
What’s Next for Global Vaccination?
The U.S. pullout from Gavi raises urgent questions:
Can Gavi re-secure funding from other nations or philanthropies in time?
Will misinformation about vaccine safety spread further into mainstream global health policy?
What precedent does this set for future international health partnerships?
Unless reversed or counterbalanced by new alliances, this decision could mark the beginning of a global immunization crisis, undoing decades of progress in child health, disease eradication, and international solidarity.
Please read this article: Sickle Cell Disease: Everything You Need to Know









Comments